Tactile Systems Technology (TCMD) EPS (Weighted Average and Diluted) Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -19.74% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.20% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.00% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 88.89% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 47.37% |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn | 38.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.46% |
| Dec 31, 2025 | 15.00% |
| Sep 30, 2025 | 71.43% |
| Jun 30, 2025 | -22.22% |
| Mar 31, 2025 | -44.44% |
| Dec 31, 2024 | 14.29% |
| Sep 30, 2024 | -77.66% |
| Jun 30, 2024 | 5,122.87% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 52.17% |
| Sep 30, 2023 | 954.55% |
| Jun 30, 2023 | 98.44% |
| Mar 31, 2023 | 88.46% |
| Dec 31, 2022 | 160.53% |
| Sep 30, 2022 | 35.29% |
| Jun 30, 2022 | -428.57% |
| Mar 31, 2022 | -550.00% |
| Dec 31, 2021 | -160.32% |
| Sep 30, 2021 | -241.67% |
| Jun 30, 2021 | 109.72% |
| Mar 31, 2021 | -71.43% |
| Dec 31, 2020 | 186.36% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | -614.29% |
| Mar 31, 2020 | -187.50% |
| Dec 31, 2019 | 83.33% |
| Sep 30, 2019 | 33.33% |
| Jun 30, 2019 | 7.69% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 28.57% |
| Jun 30, 2018 | -35.00% |
| Dec 31, 2017 | -55.56% |
| Sep 30, 2017 | 600.00% |
| Jun 30, 2017 | 400.00% |
| Mar 31, 2017 | 80.00% |
| Dec 31, 2016 | -6.90% |
| Sep 30, 2016 | -66.67% |
| Jun 30, 2016 | 133.33% |